Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped ...

Gepotidacin was approved by the FDA earlier this year, under the Blujepa brand, as the first oral antibiotic to offer a new ...

It is not clear whether Prasad will still serve as the agency’s chief medical and scientific officer, Stat reports. Meanwhile, Center for Drug Evaluation and Research staff grill top drug regulator ...

GSK plc's experimental antibiotic, gepotidacin, has been granted priority review by the U.S. Food and Drug Administration ...

[FDA headquarters in Washington DC.] JHVEPhoto GSK (NYSE:GSK [https://seekingalpha.com/symbol/GSK]) announced on Monday that ...